Newstral
Article
bizjournals.com on 2021-08-02 12:37
Drugmaker with new Waltham offices vows to fight FDA rejection
Related news
- Latest drug by Waltham drugmaker Tesaro rejected by FDAbizjournals.com
- Newton drugmaker Acer cuts more than two dozen staff after FDA rejectionbizjournals.com
- Waltham biotech gets FDA approval for drug to treat nausea after chemobizjournals.com
- Waltham company says $32M will help FDA approval for eye treatmentbizjournals.com
- FDA warns Northeast Philly drugmakerbizjournals.com
- Drugmaker Alkermes confirms expansion, hiring plans in Walthambizjournals.com
- CWalthamcbcmagazine.com
- Drugmaker resubmits women's sex pill to FDAThe Salt Lake Tribune
- Shares of Waltham drugmaker ImmunoGen crater after late-stage trial failbizjournals.com
- Waltham drugmaker Chiasma cuts another 20 employees in bid to conserve cashbizjournals.com
- Activist investor pushes for ex-Goop CEO, others to join board of Waltham drugmaker Amagbizjournals.com
- Cempra's stock down over FDA rejectionbizjournals.com
- Its opioid dissed by FDA advisors, S.F. drugmaker abandons programbizjournals.com
- Drugmaker shares plummet ahead of FDA meeting on antibioticThe Findlay Courier
- FDA asks drugmaker to stop selling its opioid painkillerKOAT 7
- Drugmaker ignored more than 200 bad quality tests, FDA saysstaradvertiser.com
- FDA asks drugmaker to remove opioid painkiller from the marketWashington Post
- Durham drugmaker preps for commercialization as it awaits FDA approvalbizjournals.com
- Drugmaker Merck asks FDA to authorize promising anti-COVID pillpressherald.com